BamSEC and AlphaSense Join Forces
Learn More

Structure Therapeutics Inc. – Material Contracts

NASDAQ: GPCR    
Share price (6/22/26): $45.51    
Market cap (6/22/26): $3.235 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 6 pages Appendix a Amended and Restated Participation Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Appendix a Amended and Restated Participation Agreement
12/34/56
EX-10.1
from 10-Q 17 pages Employment Contract 劳动合同
12/34/56
EX-10.23
from 10-K 17 pages Non-Exclusive License Agreement
12/34/56
EX-10.22
from 10-K 19 pages Structure Therapeutics Inc. Severance and Change in Control Plan
12/34/56
EX-10.17
from 10-K 3 pages Structure Therapeutics Inc. ​ Non-Employee Director Compensation Policy ​
12/34/56
EX-10.2
from 10-Q 5 pages Appendix a Participation Agreement
12/34/56
EX-10.1
from 10-Q 33 pages Certain Confidential Information Contained in This Document, Marked by […***…], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Employment Contract 劳动合同
12/34/56
EX-10.19
from 10-K 3 pages Structure Therapeutics Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 5 pages Structure Therapeutics USA Inc
12/34/56
EX-10.2
from 10-Q 3 pages ​ Structure Therapeutics USA Inc. ​
12/34/56
EX-10.1
from 10-Q 14 pages ​ Structure Therapeutics, Inc. ​
12/34/56
EX-10.2
from 10-Q 2 pages Structure Therapeutics Inc. ​ Non-Employee Director Compensation Policy ​
12/34/56
EX-10.1
from 10-Q 21 pages Employment Contract ​
12/34/56
EX-10.4
from 10-Q 100 pages Share Purchase Agreement
12/34/56
EX-10.1
from 8-K 25 pages Collaboration Agreement
12/34/56
EX-10.1
from 8-K 2 pages Structure Therapeutics Inc. Non-Employee Director Compensation Policy Effective Date: February 2, 2023 Amended by the Board: August 3, 2023
12/34/56
EX-10.3
from 8-K 15 pages This Sublease ("Sublease"), Dated as of June 29, 2023, Is Made by and Between Aligos Therapeutics, Inc., a Delaware Corporation ("Sublandlord”), and Structure Therapeutics USA Inc., a Delaware Corporation ("Subtenant"). Sublandlord and Subtenant Hereby Agree as Follows: 1. Recitals: This Sublease Is Made With Reference to the Following Facts, Intentions and Understandings
12/34/56
EX-10.2
from 8-K 50 pages House Leasing Contract Between [Shanghai Chuangzhi Space Entrepreneurship Incubator Management Co., Ltd.] and [Shanghai Shouti Biotechnology Co., Ltd.] House Leasing Contract 1 House Leasing Contract
12/34/56
EX-10.1
from 8-K 26 pages Shanghai Premises Lease Contract Important Notice
12/34/56